National and Kapodistrian University of AthensAthens, Attiki, Greece
Disclosure(s): Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD
167 - Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
Thursday, October 17, 20242:21 PM – 2:33 PM US PT
